# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-026249
Filing Date
2024-03-05
Accepted
2024-03-05 17:11:03
Documents
97
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | nktr-20231231.htm iXBRL | 10-K | 2998901
2 | EX-21.1 | nktr-ex21_1.htm | EX-21.1 | 1180
3 | EX-23.1 | nktr-ex23_1.htm | EX-23.1 | 8991
4 | EX-31.1 | nktr-ex31_1.htm | EX-31.1 | 12101
5 | EX-31.2 | nktr-ex31_2.htm | EX-31.2 | 12190
6 | EX-32.1 | nktr-ex32_1.htm | EX-32.1 | 9283
7 | EX-97 | nktr-ex97.htm | EX-97 | 38099
8 | GRAPHIC | img21475920_0.jpg | GRAPHIC | 311001
| Complete submission text file | 0000950170-24-026249.txt |  | 13975515

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | nktr-20231231.xsd | EX-101.SCH | 1831709
99 | EXTRACTED XBRL INSTANCE DOCUMENT | nktr-20231231_htm.xml | XML | 2642622

Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24006 | Film No.: 24722178
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)